Dashboard
Manage Tickers

LAB STANDARD BIOTOOLS INC.

Nasdaq fluidigm.com


$ 1.35 $ -0.07 (-4.93 %)    

Monday, 27-Oct-2025 11:29:23 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 626.53 $ 0.00 (0 %)
DIA $ 474.55 $ -0.24 (-0.05 %)
SPY $ 683.47 $ 0.68 (0.1 %)
TLT $ 91.32 $ 0.01 (0.01 %)
GLD $ 367.27 $ -3.84 (-1.04 %)
$ 1.42
$ 1.42
$ 1.34 x 1,557
$ 1.35 x 1,120
$ 1.33 - $ 1.42
$ 0.92 - $ 2.32
973,802
na
542.43M
$ 1.55
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-15-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 03-10-2025 12-31-2024 10-K
4 11-06-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-01-2024 12-31-2023 10-K
8 11-07-2023 09-30-2023 10-Q
9 08-08-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-14-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-09-2022 03-31-2022 10-Q
15 03-08-2022 12-31-2021 10-K
16 11-09-2021 09-30-2021 10-Q
17 08-06-2021 06-30-2021 10-Q
18 05-07-2021 03-31-2021 10-Q
19 02-25-2021 12-31-2020 10-K
20 11-09-2020 09-30-2020 10-Q
21 08-07-2020 06-30-2020 10-Q
22 05-11-2020 03-31-2020 10-Q
23 02-27-2020 12-31-2019 10-K
24 11-08-2019 09-30-2019 10-Q
25 08-07-2019 06-30-2019 10-Q
26 05-07-2019 03-31-2019 10-Q
27 03-18-2019 12-31-2018 10-K
28 11-06-2018 09-30-2018 10-Q
29 08-08-2018 06-30-2018 10-Q
30 05-08-2018 03-31-2018 10-Q
31 03-08-2018 12-31-2017 10-K
32 11-07-2017 09-30-2017 10-Q
33 08-08-2017 06-30-2017 10-Q
34 05-09-2017 03-31-2017 10-Q
35 03-03-2017 12-31-2016 10-K
36 11-09-2016 09-30-2016 10-Q
37 08-09-2016 06-30-2016 10-Q
38 05-09-2016 03-31-2016 10-Q
39 02-29-2016 12-31-2015 10-K
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

standard-biotools-commences-restructuring-plan-including-15-workforce-reduction
Standard BioTools Commences Restructuring ...
09/17/2025 20:07:54

-SEC Filing

standard-biotools-affirms-fy2025-sales-guidance-of-165000m-175000m-vs-169148m-est
Standard BioTools Affirms FY2025 Sales Gui...
08/11/2025 20:41:31

Standard BioTools (NASDAQ:LAB) affirms FY2025 sales outlook from $165.000 million-$175.000 million to $165.000 million-$175.000...

standard-biotools-q2-eps-from-continuing-operations-005
Standard BioTools Q2 EPS From Continuing O...
08/11/2025 20:02:35

standard-biotools-q2-eps-009-misses-008-estimate-sales-41962m-beat-39824m-estimate
Standard BioTools Q2 EPS $(0.09) Misses $(...
08/11/2025 20:02:18

Standard BioTools (NASDAQ:LAB) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(...

Core News & Articles
Earnings Scheduled For August 11, 2025
08/11/2025 08:32:28

standard-biotools-and-precise-sg100k-launch-proteomics-collaboration-with-somascan-11k-to-analyze-100000-singapore-biobank-samples
Standard BioTools And PRECISE-SG100K Launc...
08/06/2025 11:18:42

fedex-issues-soft-guidance-joins-torrid-holdings-allot-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
FedEx Issues Soft Guidance, Joins Torrid H...
06/25/2025 12:36:28

somalogic-acquisition-marks-next-step-in-illuminas-advanced-biomarker-push
SomaLogic Acquisition Marks Next Step In I...
06/23/2025 16:04:58

Illumina will acquire SomaLogic to expand in proteomics, adding new revenue streams and accelerating tech development in multio...

tesla-spartannash-standard-biotools-and-other-big-stocks-moving-higher-on-monday
Tesla, SpartanNash, Standard BioTools And ...
06/23/2025 15:07:56

Core News & Articles
CORRECTION: Standard BioToles Ticker Is "L...
06/23/2025 13:08:20

Core News & Articles
Standard BioTools Sells SomaLogic To Illum...
06/23/2025 11:10:06

Up To $425 Million In Total Proceeds Inclusive of Near-term Milestone Payments; $350 Million In Upfront Cash  Retains Strategic...

standard-biotools-affirms-fy2025-sales-guidance-of-16500m-17500m-vs-16920m-est
Standard BioTools Affirms FY2025 Sales Gui...
05/06/2025 20:02:40

Standard BioTools (NASDAQ:LAB) affirms FY2025 sales outlook from $165.00 million-$175.00 million to $165.00 million-$175.00 mil...

standard-biotools-q1-eps-007-inline-sales-4080m-beat-4010m-estimate
Standard BioTools Q1 EPS $(0.07), Inline, ...
05/06/2025 20:02:23

Standard BioTools (NASDAQ:LAB) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. This is...

Core News & Articles
Earnings Scheduled For May 6, 2025
05/06/2025 08:32:41

keybanc-downgrades-standard-biotools-to-sector-weight
Keybanc Downgrades Standard BioTools to Se...
02/27/2025 13:07:55

Keybanc analyst Paul Knight downgrades Standard BioTools (NASDAQ:LAB) from Overweight to Sector Weight.

standard-biotools-sees-fy2025-sales-165000m-175000m-vs-18693m-est
Standard BioTools Sees FY2025 Sales $165.0...
02/26/2025 21:11:53

Standard BioTools (NASDAQ:LAB) sees FY2025 sales of $165.000 million-$175.000 million vs $186.93 million analyst estimate.

standard-biotools-q4-eps-009-misses-007-estimate-sales-4672m-beat-4303m-estimate
Standard BioTools Q4 EPS $(0.09) Misses $(...
02/26/2025 21:11:14

Standard BioTools (NASDAQ:LAB) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(...

earnings-scheduled-for-february-26-2025
Earnings Scheduled For February 26, 2025
02/26/2025 08:32:32

intra-cellular-therapies-standard-biotools-si-bone-and-other-big-stocks-moving-higher-on-monday
Intra-Cellular Therapies, Standard BioTool...
01/13/2025 15:57:29

standard-biotools-announced-preliminary-revenue-for-q4-and-fy-2024-of-approximately-465m-and-174m-respectively-compared-to-consensus-of-4303m-and-17120m
Standard BioTools Announced Preliminary Re...
01/13/2025 12:04:24

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION